Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Metabolon and Genomics England Announce Partnership to Characterize Hundreds of Rare Diseases and Advance Rare Disease Diagnosis 2023-10-25 19:57
Good Safety Profile and Antitumor Activity: Oral Presentation of Mabwell's 9MW2821 at 2023 ESMO 2023-10-25 17:46
AMS BioteQ Makes Debut at Medical Japan 2023: Bringing Innovative Healthcare into New Horizons 2023-10-25 13:06
GC Cell Joins U.S Cancer Moonshot Project 2023-10-25 11:27
Snapdragon Chemistry, a Cambrex Company, Recognized with CPhI Pharma Award for API Development 2023-10-25 04:18
Cyrus K. Mirsaidi Named Global CEO to Bridgewest Perth Pharma 2023-10-24 23:17
Wolters Kluwer Applauded by Frost & Sullivan for Improving Healthcare Efficiencies, Quality, and Outcomes and for Its Competitive Strategies 2023-10-24 21:30
First Immunotherapy Success in TKI-Resistant Lung Cancer Setting Demonstrates Power of AI-driven Immune Phenotyping by Lunit SCOPE IO - newly published in JCO 2023-10-24 21:00
Phase Ib/II Results of Akeso's PD-1/CTLA-4 Bispecific Antibody for First-Line Treatment of Advanced Hepatocellular Carcinoma Published at 2023 ESMO 2023-10-24 20:00
OrbiMed Raises $4.3 Billion Across Private Investment Funds 2023-10-24 19:30
Life Molecular Imaging and Sinotau Pharmaceutical Group Announce the Regulatory Approval of their Amyloid PET Imaging Radiopharmaceutical Neuraceq® in China 2023-10-24 16:00
Clinical Trial Application (IND) for BioRay Pharmaceutical's BR105 Injection Receives U.S. FDA Approval 2023-10-24 15:05
Recbio appeared at the 14th China (Taizhou) International Pharmaceutical Fair 2023-10-24 13:39
OBiO Announces Strategic Partnership with Refreshgene to Realize Commercialization of Gene Therapy Product 2023-10-24 12:05
Singapore-based Juniper Biologics Awarded the Most Innovative Oncology Pharmaceutical Company 2023 by GHP Healthcare and Pharmaceutical Awards 2023-10-24 12:00
Cellomics announces Mr. Andy A. Liu as new Group CEO of the Company 2023-10-24 12:00
CCTV+: Jianchangbang Pharmacy: A Thousand Years of Tradition and Excellence 2023-10-24 11:51
Based on recent data presented at 2023 ESMO, the innovative TROP2 ADC SKB264 (MK-2870) shows promising prospects for the treatment of patients with HR+/HER2- metastatic breast cancer who have undergone multiple prior lines of therapy , and its clinical development in other solid tumors is also advancing steadily 2023-10-24 10:19
Wingderm® Has Unveiled the Latest Research of Mesoskin for Mesotherapy Treatment at AMWC 2023-10-24 09:23
Alphamab Oncology updated data from two studies of KN026 in combination with docetaxel for HER2-positive breast cancer at ESMO 2023-10-24 08:41
1 147 148 149 150 151 976